Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microbiome Therapy for COVID-19 Primary Care Support
NCT04793997Suspended
- Start
- Feb 2021
- Primary completion
- Feb 2022
- Countries
- 1
01
Overview
Randomised, double-blind trial in coronavirus disease 2019 (COVID-19) (3 arms). Primary endpoint: Change in severity of COVID-19 infection symptoms at 3 weeks. Started Feb 2021; status: suspended.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04793997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04793997.